Gene · 79718
Papers1,924
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 1,924
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Molecular Weight-Dependent Oxidation and Optoelectronic Properties of Defect-Free Macrocyclic Poly(3-hexylthiophene). | Polymers (Basel) | 2023 | 36771966 | PubTator, text mining | PubMed |
| In Silico Tools to Extract the Drug Design Information Content of Degradation Data: The Case of PROTACs Targeting the Androgen Receptor. | Molecules | 2023 | 36770875 | PubTator, text mining | PubMed |
| The Landscape of Secondary Genetic Rearrangements in Pediatric Patients with B-Cell Acute Lymphoblastic Leukemia with t(12;21). | Cells | 2023 | 36766699 | PubTator, text mining | PubMed |
| The Immunology of DLBCL. | Cancers (Basel) | 2023 | 36765793 | PubTator, text mining | PubMed |
| Enhanced control structure design for an industrial off-gas system: Simple reconfigurations benefit the economy. | Heliyon | 2023 | 36704278 | PubTator, text mining | PubMed |
| Novel Arthrogryposis Multiplex Congenita Presentation in a Newborn With Pierpont Syndrome. | J Investig Med High Impact Case Rep | 2023 | 36691917 | PubTator, text mining | PubMed |
| Identification of Novel CSF-Derived miRNAs in Treated Paediatric Onset Spinal Muscular Atrophy: An Exploratory Study. | Pharmaceutics | 2023 | 36678797 | PubTator, text mining | PubMed |
| The Molecular Characterization of Genetic Abnormalities in Esophageal Squamous Cell Carcinoma May Foster the Development of Targeted Therapies. | Curr Oncol | 2023 | 36661697 | PubTator, text mining | PubMed |
| Anti-Inflammatory Role of TRPV4 in Human Macrophages. | Immunohorizons | 2023 | 36645854 | PubTator, text mining | PubMed |
| Optimal Recursive Expert-Enabled Inference in Regulatory Networks. | IEEE Control Syst Lett | 2023 | 36644010 | PubTator, text mining | PubMed |
| Critical digital ischemia and biliary cholangitis related to graft versus host disease: A case report and systematic literature review. | Medicine (Baltimore) | 2023 | 36637943 | PubTator, text mining | PubMed |
| Multi-region sequencing depicts intratumor heterogeneity and clonal evolution in cervical cancer. | Med Oncol | 2023 | 36635412 | PubTator, text mining | PubMed |
| Meta-Analysis of MS-Based Proteomics Studies Indicates Interferon Regulatory Factor 4 and Nucleobindin1 as Potential Prognostic and Drug Resistance Biomarkers in Diffuse Large B Cell Lymphoma. | Cells | 2023 | 36611989 | PubTator, text mining | PubMed |
| Gene signature and prognostic value of ubiquitination-related genes in endometrial cancer. | World J Surg Oncol | 2023 | 36611207 | PubTator, text mining | PubMed |
| Characterization of the TBR1 interactome: variants associated with neurodevelopmental disorders disrupt novel protein interactions. | Hum Mol Genet | 2023 | 36579832 | PubTator, text mining | PubMed |
| Systematic identification and characterization of repressive domains in Drosophila transcription factors. | EMBO J | 2023 | 36545802 | PubTator, text mining | PubMed |
| The oncogenic driving force of CD30 signaling-induced chromosomal instability in adult T-cell leukemia/lymphoma. | Cancer Sci | 2023 | 36541483 | PubTator, text mining | PubMed |
| Lymphoma-associated mutations in autoreactive memory B cells of patients with Sjögren's syndrome. | J Pathol | 2023 | 36426826 | PubTator, text mining | PubMed |
| Circulating miRNAs Respond to Denosumab Treatment After 2 Years in Postmenopausal Women With Osteoporosis-the MiDeTe study. | J Clin Endocrinol Metab | 2023 | 36408612 | PubTator, text mining | PubMed |
| An integrated interval-valued intuitionistic fuzzy technique for resumption risk assessment amid COVID-19 prevention. | Inf Sci (N Y) | 2023 | 36406041 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/79718/papers?page=13